1978 Nobel Prize in Physiology or Medicine — Arber, Smith, and Nathans: Restriction Enzymes Usher in the Era of Genetic Engineering

What You Will Learn

Understand how bacterial enzymes, evolved to defend against bacteriophage invasion, became a pivotal tool in genetic engineering; the story of Arber first predicting the existence of restriction enzymes, Smith actually discovering them, and Nathans utilizing them as a tool; and how this discovery paved the way for recombinant insulin, growth hormone, interferon, gene therapy, and CRISPR today.

A Story Different from Common Knowledge — Nature Already Possessed DNA Editing Tools

Let's set out the background of restriction enzymes. Arber, Smith, and Nathans — three men — discovered restriction enzymes, which are essential for genetic manipulation and molecular biology research, and established methods for using these enzymes in genetic manipulation. Although bacteria are single-celled organisms and possess no immune system, they have their own way of defending themselves against invading bacteriophages. The mechanism is this — they use specific enzymes to selectively degrade the DNA of the invading virus while leaving their own DNA untouched. These enzymes are the restriction enzymes. Hundreds of different restriction enzymes have been discovered to date, and they generally recognize a palindromic DNA base sequence of 4 to 8 base pairs and cut it.

The reason this discovery is remarkable is that nature had already created a tool for cutting DNA at precise locations. It was not invented by humans but rather discovered.

Mechanism of Action of Restriction Enzymes:

• Recognition of Specific DNA Sequences: Each restriction enzyme recognizes its unique 4-8 base pair sequence. Example: EcoRI recognizes GAATTC.
• Palindromic Sequences: Most recognition sequences are palindromic, meaning that they read the same forward and backward on complementary strands. The complement of GAATTC is CTTAAG, which, when reversed, is GAATTC. Thus, both strands of the DNA double helix have the same sequence symmetrically.
• Cleavage of Both Strands: When the recognition sequence is encountered, both strands are cut at a specific location. Depending on the type, the ends are either sticky ends or blunt ends.

This precise accuracy is crucial. When humans attempt to cut DNA using chemical or physical methods, it is cut at random locations, but restriction enzymes always cut at precise locations. The ability to precisely divide DNA into desired fragments opened up the possibilities of genetic engineering.

In the language of computer science, this discovery is a natural realization of regular expressions (regex). It is a tool that precisely matches and cuts specific patterns (e.g., GAATTC). Just as regular expressions manipulate strings, restriction enzymes manipulate DNA sequences — string processing and genetic manipulation use fundamentally the same principles.

A Glimpse of a New Era

1978 was a year in which several signs of a new era emerged.

In world history, Pope John Paul II was inaugurated in October — the first non-Italian Pope in 455 years, from Poland. Later, he played a significant role in the collapse of Eastern European communism by supporting Solidarity in Poland. On July 25, the world's first test-tube baby, Louise Brown, was born in the UK, marking the beginning of the era of artificial insemination. In September, the "Black Friday" protests took place in Iran — a prelude to the Iranian Revolution. In September, the Camp David Accords were signed — the Egypt-Israel peace treaty, a major turning point in Middle Eastern diplomacy.

In Korean history, it was a time when political control was strengthened in the run-up to the re-election of the Yushin system. The June 26 Carter visit protest and the intensification of resistance in academic circles.

In this era, the Nobel Committee recognized the discovery that opened the door to genetic engineering. One of the signs of the new era was revealed in the laboratory.

The Three Laureates — A Swiss-American Three-Step Lineage

Werner Arber (1929–) is a Swiss biochemist. He received his PhD from the Swiss Federal Institute of Technology (1958), was a professor at the University of Geneva (1960–1970), and a professor at the University of Basel (1971–). His key contribution was theoretically predicting the existence of restriction enzymes in the early 1960s.

Arber observed that certain bacteriophages could infect some strains of bacteria but not others. He hypothesized that the cause of this "restriction" phenomenon was that specific enzymes in bacteria degrade the phage DNA. However, he did not actually isolate the enzyme.

Hamilton Smith (1931–) is an American microbiologist. He received his MD from Johns Hopkins University (1956) and has been a professor at Johns Hopkins University (1967–). His key contribution was actually isolating and characterizing the first restriction enzyme. In 1970, he isolated the HindII restriction enzyme from Haemophilus influenzae and demonstrated that it cuts at a specific sequence (GTYRAC). This was the moment when Arber's prediction was confirmed.

Daniel Nathans (1928–1999) was an American microbiologist. He received his MD from Washington University (1954) and was a professor at Johns Hopkins University (1962–1999). His key contribution was developing a method for using restriction enzymes as actual research tools. He developed a method for cutting the genome of the monkey virus SV40 with several restriction enzymes and mapping the fragments (restriction map), which became the basis for all gene maps.

Nathans' background carries a particularly moving story.

His parents were Russian Jewish immigrants who came to the United States in the early 1900s in search of freedom. They had nine children, and Nathans was the youngest. Born in Wilmington, Delaware, in 1928, he arrived in a country deep in the Great Depression, and his father lost his job as soon as he was born. The house was cold and leaked, and his parents were so financially impoverished that they routinely went without meals themselves to feed their children. In spite of all this, his parents refused to lose their sense of humor and poured all their hopes into their children. Astonishingly, Nathans later recalled this period as "beautiful" — because his parents' love, care, and attention filled the household.

The story of the youngest child of poor Russian Jewish immigrants who came to the United States during the Great Depression receiving the Nobel Prize 40 years later. It is a case where love in material poverty led to knowledge.

The Pivotal Discovery — Cutting and Recombining

The reason why the discovery of restriction enzymes marked the beginning of genetic engineering can be summarized as follows.

Research on DNA had been ongoing for decades, but it was only after restriction enzymes were discovered that DNA recombination technology became a practical reality, and this was quickly followed by the emergence of DNA cloning — the mass replication of recombinant DNA.

Restriction enzymes effectively opened up a new field called genetic engineering, and starting in the 1980s, genetic engineering expanded into the improvement of animal and plant varieties, mass production of useful drugs such as insulin, growth hormone, and interferon, and even environmental cleanup, making a decisive contribution to human welfare.

Principle of Recombinant DNA Technology:

• Two different DNAs are cut with the same restriction enzyme — for example, human insulin gene and E. coli plasmid are cut with EcoRI.
• The sticky ends are complementary, so they can bind — the two different DNA fragments join together.
• DNA ligase binds them, completing the recombinant plasmid with the inserted insulin gene.
• Introduced into E. coli — E. coli maintains this plasmid and produces human insulin.
• Large-scale production of insulin — large-scale culture of E. coli → large-scale recovery of human insulin.

Recombinant human insulin was approved in 1982 and is now used by hundreds of millions of diabetic patients worldwide. Previously, animal insulin extracted from pig or cow pancreases was used, which had problems such as allergies and irregular supply. Genetic engineering solved this problem.

The subsequent expansion of this flow runs as follows. Most recently, recombinant DNA techniques are being applied to gene therapy that targets genetic diseases directly. Gene therapy involves isolating a normal gene, inserting it into a delivery vector through genetic manipulation, assembling a recombinant DNA construct, introducing it into the patient's cells, and thereby replacing the patient's abnormal gene with a normal one. Since the U.S. National Institutes of Health (NIH) first approved clinical trials of gene therapy in 1988, this field has taken its place as a core research axis in genetic engineering.

Restriction enzymes = the first tool of genetic engineering, from which several improved tools have since been derived.

A Legacy that Continues Today

The impact of this discovery can be summarized as follows. Restriction enzymes provided a revolutionary tool for genetic research. Because large genes could now be cut into fragments of a size suitable for study, nucleotide sequence analysis became far more tractable. In the end, the discovery of restriction enzymes, combined with the development of DNA sequencing methods (Frederick Sanger, Nobel Prize in Chemistry 1958 and 1980), became the two pillars that opened the era of genetic engineering and biotechnology.

This flow continues to this day.

• Recombinant protein drugs: Insulin (1982), growth hormone, interferon, EPO, and several clotting factors. A significant portion of the world's top-selling drugs.
• Gene therapy: Several gene therapies have been approved for diseases such as SMA, sickle cell anemia, spinal muscular atrophy, and inherited retinal diseases.
• CAR-T cell therapy: A breakthrough therapy for leukemia and lymphoma. Genetic engineering is expanding into cell therapy.
• CRISPR gene editing: A programmable version of restriction enzymes. 2020 Nobel Prize in Chemistry.
• Standardization of DNA sequencing: Large genomes are divided into several fragments, sequenced, and then assembled. The basis for the Human Genome Project.
• Genetic diagnostics: Diagnosis of various genetic and infectious diseases using PCR and sequencing.
• Genetically modified crops (GMOs): Crops with improved resistance to pests and the environment. Has a significant impact on global food supply.

Why It Matters

What the three laureates left behind is the fundamental demonstration that "tools created by nature can be reused for human purposes."

Bacteria evolved restriction enzymes for self-defense. Humans discovered these enzymes and reused them for their own purposes (genetic engineering). The principle that observing nature is the way to obtain tools is now a perspective we take for granted. CRISPR is the same story — discovered from a bacterial defense system against phages and became a gene-editing tool.

This principle is the most basic example of biomimicry. Human technology reproduces and reuses the sophisticated tools, structures, and principles that nature has discovered through evolution. The entire biotechnology industry of the late 20th century was built on this principle.

The story of Nathans, the youngest child of poor Jewish immigrant parents during the Great Depression, is a testament to this. As he recalled, "the time when he was surrounded by his parents' love, care, and attention was beautiful." Material deprivation did not lead to a lack of love, and that love led to a Nobel Prize.

1978 Arber, Smith, and Nathans Summary: Arber theoretically predicted the existence of restriction enzymes (1960s), Smith isolated the first restriction enzyme HindII (1970), and Nathans developed a method for using restriction enzymes as tools (1970s). Bacterial phage defense systems were reused as fundamental tools in genetic engineering. The theoretical roots of recombinant insulin, gene therapy, CRISPR, and GMOs today.

→ Previous: 1977 — Guillemin, Schally, and Yalow → Next: 1979 — Cormack and Hounsfield and CT